• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

展示于蛋白质纳米颗粒上的GWH1抗菌肽的体内杀菌功效:抗生素的一种潜在替代品

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics.

作者信息

Carratalá Jose V, Brouillette Eric, Serna Naroa, Sánchez-Chardi Alejandro, Sánchez Julieta M, Villaverde Antonio, Arís Anna, Garcia-Fruitós Elena, Ferrer-Miralles Neus, Malouin François

机构信息

Institute for Biotechnology and Biomedicine, Autonomous University of Barcelona, Bellaterra, 08193 Barcelona, Spain.

Department of Genetics and Microbiology, Autonomous University of Barcelona, Bellaterra, 08193 Barcelona, Spain.

出版信息

Pharmaceutics. 2020 Dec 17;12(12):1217. doi: 10.3390/pharmaceutics12121217.

DOI:10.3390/pharmaceutics12121217
PMID:33348529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766456/
Abstract

Oligomerization of antimicrobial peptides into nanosized supramolecular complexes produced in biological systems (inclusion bodies and self-assembling nanoparticles) seems an appealing alternative to conventional antibiotics. In this work, the antimicrobial peptide, GWH1, was N-terminally fused to two different scaffold proteins, namely, GFP and IFN-γ for its bacterial production in the form of such recombinant protein complexes. Protein self-assembling as regular soluble protein nanoparticles was achieved in the case of GWH1-GFP, while oligomerization into bacterial inclusion bodies was reached in both constructions. Among all these types of therapeutic proteins, protein nanoparticles of GWH1-GFP showed the highest bactericidal effect in an in vitro assay against , whereas non-oligomerized GWH1-GFP and GWH1-IFN-γ only displayed a moderate bactericidal activity. These results indicate that the biological activity of GWH1 is specifically enhanced in the form of regular multi-display configurations. Those in vitro observations were fully validated against a bacterial infection using a mouse mastitis model, in which the GWH1-GFP soluble nanoparticles were able to effectively reduce bacterial loads.

摘要

抗菌肽在生物系统中形成纳米级超分子复合物(包涵体和自组装纳米颗粒)的低聚化似乎是传统抗生素的一个有吸引力的替代方案。在这项工作中,抗菌肽GWH1在N端与两种不同的支架蛋白,即绿色荧光蛋白(GFP)和干扰素-γ(IFN-γ)融合,以便以这种重组蛋白复合物的形式进行细菌生产。GWH1-GFP能形成规则的可溶性蛋白纳米颗粒实现蛋白自组装,而两种构建体都能寡聚形成细菌包涵体。在所有这些类型的治疗性蛋白中,GWH1-GFP的蛋白纳米颗粒在体外针对[具体细菌名称未给出]的检测中显示出最高的杀菌效果,而非寡聚化的GWH1-GFP和GWH1-IFN-γ仅表现出中等的杀菌活性。这些结果表明,GWH1的生物活性以规则的多展示构型形式得到特异性增强。使用小鼠乳腺炎模型针对细菌感染对这些体外观察结果进行了充分验证,其中GWH1-GFP可溶性纳米颗粒能够有效降低细菌载量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/18c5fd8c92bb/pharmaceutics-12-01217-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/c731028f54ff/pharmaceutics-12-01217-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/9276df1b740f/pharmaceutics-12-01217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/5200621af5b8/pharmaceutics-12-01217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/e1d9dd195d77/pharmaceutics-12-01217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/dc083c99a1a0/pharmaceutics-12-01217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/3981fa41bda4/pharmaceutics-12-01217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/53faa4ed95a9/pharmaceutics-12-01217-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/18c5fd8c92bb/pharmaceutics-12-01217-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/c731028f54ff/pharmaceutics-12-01217-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/9276df1b740f/pharmaceutics-12-01217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/5200621af5b8/pharmaceutics-12-01217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/e1d9dd195d77/pharmaceutics-12-01217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/dc083c99a1a0/pharmaceutics-12-01217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/3981fa41bda4/pharmaceutics-12-01217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/53faa4ed95a9/pharmaceutics-12-01217-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/7766456/18c5fd8c92bb/pharmaceutics-12-01217-g007.jpg

相似文献

1
In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics.展示于蛋白质纳米颗粒上的GWH1抗菌肽的体内杀菌功效:抗生素的一种潜在替代品
Pharmaceutics. 2020 Dec 17;12(12):1217. doi: 10.3390/pharmaceutics12121217.
2
Protein-only, antimicrobial peptide-containing recombinant nanoparticles with inherent built-in antibacterial activity.具有内在抗菌活性的仅含蛋白质、含抗菌肽的重组纳米颗粒。
Acta Biomater. 2017 Sep 15;60:256-263. doi: 10.1016/j.actbio.2017.07.027. Epub 2017 Jul 19.
3
Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation.抗菌肽以创新的缓释药物制剂形式的高效递送。
Pharmaceutics. 2023 Nov 16;15(11):2632. doi: 10.3390/pharmaceutics15112632.
4
Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.招募具有强大膜穿透性的肿瘤细胞靶向蛋白纳米颗粒。
Nanotechnology. 2019 Mar 15;30(11):115101. doi: 10.1088/1361-6528/aaf959. Epub 2018 Dec 18.
5
Developing Protein-Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents.研发蛋白-抗肿瘤药物纳米偶联物作为双功能抗菌剂。
ACS Appl Mater Interfaces. 2020 Dec 30;12(52):57746-57756. doi: 10.1021/acsami.0c18317. Epub 2020 Dec 16.
6
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4.肿瘤标志物CXCR4的特异性肽配体T22的抗菌活性
Pharmaceutics. 2021 Nov 13;13(11):1922. doi: 10.3390/pharmaceutics13111922.
7
Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.针对大肠杆菌O157:H7、铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌的杀菌肽设计
Med Chem. 2018;14(7):741-752. doi: 10.2174/1573406414666180508120024.
8
Self-Assembling Myristoylated Human α-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection.自组装豆蔻酰化人 α-防御素 5 作为下一代纳米药物可增强细菌感染的治疗效果。
ACS Nano. 2018 Jun 26;12(6):5284-5296. doi: 10.1021/acsnano.7b09109. Epub 2018 Jun 8.
9
Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.银纳米颗粒对乳腺炎感染山羊的多重耐药金黄色葡萄球菌和铜绿假单胞菌菌株的影响:抗菌治疗的一种替代方法。
Int J Mol Sci. 2017 Mar 6;18(3):569. doi: 10.3390/ijms18030569.
10
Nanoparticle-mediated delivery of the antimicrobial peptide plectasin against Staphylococcus aureus in infected epithelial cells.纳米颗粒介导的抗菌肽plecatin对感染上皮细胞中的金黄色葡萄球菌的递送
Eur J Pharm Biopharm. 2015 May;92:65-73. doi: 10.1016/j.ejpb.2015.02.009. Epub 2015 Feb 18.

引用本文的文献

1
Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography.通过 N-月桂酰肌氨酸辅助亲和层析从粗菌细胞提取物中增强重组蛋白的捕获、纯度和产率。
Microb Cell Fact. 2023 Apr 25;22(1):81. doi: 10.1186/s12934-023-02081-7.
2
The future of recombinant host defense peptides.重组宿主防御肽的未来。
Microb Cell Fact. 2022 Dec 21;21(1):267. doi: 10.1186/s12934-022-01991-2.
3
Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells.人源Caco-2细胞中细菌包涵体的毒性分析

本文引用的文献

1
Nanostructured antimicrobial peptides: The last push towards clinics.纳米结构抗菌肽:迈向临床的最后一推。
Biotechnol Adv. 2020 Nov 15;44:107603. doi: 10.1016/j.biotechadv.2020.107603. Epub 2020 Jul 29.
2
Artificial Inclusion Bodies for Clinical Development.用于临床开发的人工包涵体
Adv Sci (Weinh). 2019 Nov 27;7(3):1902420. doi: 10.1002/advs.201902420. eCollection 2020 Feb.
3
Aggregation-prone peptides modulate activity of bovine interferon gamma released from naturally occurring protein nanoparticles.易于聚集的肽调节天然存在的蛋白质纳米颗粒释放的牛干扰素 γ 的活性。
Front Bioeng Biotechnol. 2022 Apr 29;10:842256. doi: 10.3389/fbioe.2022.842256. eCollection 2022.
4
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4.肿瘤标志物CXCR4的特异性肽配体T22的抗菌活性
Pharmaceutics. 2021 Nov 13;13(11):1922. doi: 10.3390/pharmaceutics13111922.
N Biotechnol. 2020 Jul 25;57:11-19. doi: 10.1016/j.nbt.2020.02.001. Epub 2020 Feb 3.
4
Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.工程化分泌型淀粉样纤维以实现对转移灶的远程且高度选择性的破坏。
Adv Mater. 2020 Feb;32(7):e1907348. doi: 10.1002/adma.201907348. Epub 2019 Dec 27.
5
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies.通过局部给药功能性包涵体将抗肿瘤蛋白靶向递送至乳腺癌
Adv Sci (Weinh). 2019 Jul 24;6(18):1900849. doi: 10.1002/advs.201900849. eCollection 2019 Sep 18.
6
Evaluation of a Rhodomyrtus tomentosa ethanolic extract for its therapeutic potential on Staphylococcus aureus infections using in vitro and in vivo models of mastitis.评价桃金娘乙醇提取物在乳腺炎的体外和体内模型中治疗金黄色葡萄球菌感染的潜力。
Vet Res. 2019 Jun 20;50(1):49. doi: 10.1186/s13567-019-0664-9.
7
Membrane targeting cationic antimicrobial peptides.靶向细胞膜的阳离子抗菌肽。
J Colloid Interface Sci. 2019 Mar 1;537:163-185. doi: 10.1016/j.jcis.2018.10.103. Epub 2018 Nov 1.
8
Design and production of a novel antimicrobial fusion protein in Escherichia coli.在大肠杆菌中设计和生产一种新型抗菌融合蛋白。
Appl Microbiol Biotechnol. 2018 Oct;102(20):8763-8772. doi: 10.1007/s00253-018-9319-4. Epub 2018 Aug 17.
9
Antimicrobial resistance in bacteria isolated from mastitis in dairy cattle in France, 2006-2016.法国 2006-2016 年奶牛乳腺炎分离细菌的抗菌药物耐药性
J Dairy Sci. 2018 Oct;101(10):9451-9462. doi: 10.3168/jds.2018-14835. Epub 2018 Aug 9.
10
Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.新型抗菌活性杂合肽的表达、纯化与鉴定。
Molecules. 2018 Jun 20;23(6):1491. doi: 10.3390/molecules23061491.